Control of occult hepatitis B virus infection

The diagnosis of hepatitis B virus (HBV) infection requires HBV DNA testing and serologic testing for detection of the surface antigen (HBsAg) and the hepatitis B core antibody (anti-HBc). There is a population of patients with occult HBV infection (OBI), which is not detected by HBsAg or HBV DNA qu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Advances in Laboratory Medicine / Avances en Medicina de Laboratorio 2022-12, Vol.3 (4), p.321-330
Hauptverfasser: Lalana Garcés, Marta, Ortiz Pastor, Oihana, Solé Enrech, Gemma, Guerra-Ruiz, Armando R., Casals Mercadal, Gregori, Almería Lafuente, Alejandro, Ballesteros Vizoso, María Antonieta, Medina, Pablo Gabriel, Salgüero Fernández, Sergio, Zamora Trillo, Angielys, Aured de la Serna, Isabel, Hurtado, Juan Carlos, Pérez-Del-Pulgar, Sofía, Forns, Xavier, Morales Ruiz, Manuel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The diagnosis of hepatitis B virus (HBV) infection requires HBV DNA testing and serologic testing for detection of the surface antigen (HBsAg) and the hepatitis B core antibody (anti-HBc). There is a population of patients with occult HBV infection (OBI), which is not detected by HBsAg or HBV DNA quantification in blood, despite the presence of active replication in the liver. This document provides a definition of OBI and describes the diagnostic techniques currently used. It also addresses the detection of patients with risk factors and the need for screening for OBI in these patients. Correct diagnosis of OBI prevents HBV reactivation and transmission. Diagnosis of OBI is based on the detection of HBV DNA in patients with undetectable HBsAg in blood. A high number of patients with OBI may remain undiagnosed; therefore, screening for OBI in patients with factor risks is essential. For a correct diagnosis of OBI, it is necessary that new markers such as ultrasensitive HBsAg are incorporated, and a more comprehensive marker study is performed by including markers such as cccDNA.
ISSN:2628-491X
2628-491X
DOI:10.1515/almed-2022-0065